A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.

NCT ID: NCT01302054

Last Updated: 2018-12-04

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

990 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-05-31

Study Completion Date

2012-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with overactive bladder are often treated with tolterodine, a medication that helps relax the bladder, helping symptoms of urinary incontinence and urinary frequency. Sometimes patients do not have a satisfactory response, and may benefit from trying an alternative oral medicine. Fesoterodine is related to tolterodine by producing the same active substance that acts on the bladder, but potentially at higher and more effective levels. So, a patient who has a poor response to tolterodine may still obtain a good response to fesoterodine. This study will help find out if this is what happens.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Bladder, Overactive

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fesoterodine

Group Type EXPERIMENTAL

Fesoterodine 8 mg

Intervention Type DRUG

Fesoterodine sustained release tablets once every morning at 4 mg dose for first week, followed by 11 weeks at 8 mg strength.

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Matching placebo for fesoterodine 4 and 8 mg for a total of 12 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fesoterodine 8 mg

Fesoterodine sustained release tablets once every morning at 4 mg dose for first week, followed by 11 weeks at 8 mg strength.

Intervention Type DRUG

Placebo

Matching placebo for fesoterodine 4 and 8 mg for a total of 12 weeks.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Toviaz

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of overactive bladder with symptoms for at least 6 months.
* Moderate to severe incontinence episode frequency and subsequent sub-optimal response to tolterodine
* Women of child-bearing potential must not intend to become pregnant, be pregnant or producing breast milk at the time of study entry, and must use contraception

Exclusion Criteria

* Conditions or prior treatment that may also affect bladder function
* Clinically significant urinary tract infection (UTI)
* Ongoing treatment with overactive bladder medications (these can be stopped at the first visit to allow entry into the study).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pfizer

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pfizer CT.gov Call Center

Role: STUDY_DIRECTOR

Pfizer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Radiant Research, Inc.

Birmingham, Alabama, United States

Site Status

Alabama Internal Medicine, PC

Birmingham, Alabama, United States

Site Status

Brown and McCool Gynecology

Fairhope, Alabama, United States

Site Status

Radiant Research, Inc.

Chandler, Arizona, United States

Site Status

Eclipse Clinical Research

Green Valley, Arizona, United States

Site Status

Radiant Research, Inc.

Tucson, Arizona, United States

Site Status

Urological Associates of Southern Arizona, PC

Tucson, Arizona, United States

Site Status

American Institute of Research

Los Angeles, California, United States

Site Status

Moaz Khorsandi, DO

Los Angeles, California, United States

Site Status

Urology Group of Southern California

Los Angeles, California, United States

Site Status

Institute for Advanced Urology

Los Angeles, California, United States

Site Status

Center for Clinical Trials, LLC

Paramount, California, United States

Site Status

Sierra Clinical Research

Roseville, California, United States

Site Status

Superior Research LLC

Sacramento, California, United States

Site Status

California Research Foundation

San Diego, California, United States

Site Status

Medical Center for Clinical Research

San Diego, California, United States

Site Status

Advanced Urology, PC

Parker, Colorado, United States

Site Status

Thameside Obstetrics/Gynecological Center

Groton, Connecticut, United States

Site Status

S.H.E. Medical Associates

Hartford, Connecticut, United States

Site Status

Chase Medical Research, LLC

Waterbury, Connecticut, United States

Site Status

Manatee Medical Research Institute, LLC

Bradenton, Florida, United States

Site Status

Atlantic Institute of Clinical Research

Daytona Beach, Florida, United States

Site Status

SJS Clinical Research

Destin, Florida, United States

Site Status

Ocala Urology Specialists

Ocala, Florida, United States

Site Status

Renstar Medical Research, Inc.

Ocala, Florida, United States

Site Status

Accord Clinical Research, LLC

Port Orange, Florida, United States

Site Status

Pinellas Urology, Inc.

St. Petersburg, Florida, United States

Site Status

Florida Urology Partners

Tampa, Florida, United States

Site Status

The Office of Georgis Patsias, MD, PA

Wellington, Florida, United States

Site Status

Palm Beach Research Center

West Palm Beach, Florida, United States

Site Status

Atlanta Medical Research Institute, LLC

Alpharetta, Georgia, United States

Site Status

Radiant Research, Inc.

Atlanta, Georgia, United States

Site Status

In-Quest Medical Research, LLC

Duluth, Georgia, United States

Site Status

Prism Research Group

Rome, Georgia, United States

Site Status

Valley Health Care

Rome, Georgia, United States

Site Status

Fox Valley Clinical Research Center, LLC

Aurora, Illinois, United States

Site Status

Radiant Research, Inc.

Chicago, Illinois, United States

Site Status

Urology of Indiana, LLC

Noblesville, Indiana, United States

Site Status

Radiant Research, Inc.

Overland Park, Kansas, United States

Site Status

Regional Urology, LLC

Shreveport, Louisiana, United States

Site Status

New England Center for Clinical Research Fall River, LLC

Fall River, Massachusetts, United States

Site Status

New England Center for Clinical Research of Massachusetts, LLC

New Bedford, Massachusetts, United States

Site Status

Bay State Clinical Trials, Inc.

Watertown, Massachusetts, United States

Site Status

Beyer Research

Kalamazoo, Michigan, United States

Site Status

Medical Research Associates, Inc.

Traverse City, Michigan, United States

Site Status

Radiant Research, Inc.

Edina, Minnesota, United States

Site Status

Adult and Pediatric Urology

Sartell, Minnesota, United States

Site Status

CRC of Jackson

Jackson, Mississippi, United States

Site Status

Women's Specialty Center

Jackson, Mississippi, United States

Site Status

The Urology Group

Southaven, Mississippi, United States

Site Status

Radiant Research, Inc.

St Louis, Missouri, United States

Site Status

Quality Clinical Research, Inc.

Omaha, Nebraska, United States

Site Status

Francis Jimenez, MD

Las Vegas, Nevada, United States

Site Status

Impact Clinical Trials

Las Vegas, Nevada, United States

Site Status

Richard M. Groom, MD

Las Vegas, Nevada, United States

Site Status

Northeast Urogynecology

Albany, New York, United States

Site Status

The Urologic Institute of Northeastern New York - Community Care Physicians, PC

Albany, New York, United States

Site Status

University Urology Associates

New York, New York, United States

Site Status

Associated Medical Professionals of New York, PLLC

Oneida, New York, United States

Site Status

Associated Medical Professionals of NY

Syracuse, New York, United States

Site Status

PMG Research of Raleigh, LLC d/b/a PMG Research of Cary

Cary, North Carolina, United States

Site Status

PMG Research of Charlotte

Charlotte, North Carolina, United States

Site Status

Urology Specialists of the Carolinas

Charlotte, North Carolina, United States

Site Status

PMG Research of Raleigh, LLC

Raleigh, North Carolina, United States

Site Status

PMG Research of Salisbury, LLC

Salisbury, North Carolina, United States

Site Status

Salibury Urological Clinic

Salisbury, North Carolina, United States

Site Status

Carolina Urological Associates

Winston-Salem, North Carolina, United States

Site Status

PMG Research of Winston-Salem, LLC

Winston-Salem, North Carolina, United States

Site Status

Lillestol Research LLC

Fargo, North Dakota, United States

Site Status

Radiant Research, Inc.

Akron, Ohio, United States

Site Status

Radiant Research, Inc.

Cincinnati, Ohio, United States

Site Status

Radiant Research, Inc.

Columbus, Ohio, United States

Site Status

Providence Health Partners - Center for Clinical Research

Dayton, Ohio, United States

Site Status

Central Sooner Research

Norman, Oklahoma, United States

Site Status

Pacific Women's Center, LLC

Eugene, Oregon, United States

Site Status

Urologic Consultants of Southeastern Pennsylvania

Bala-Cynwyd, Pennsylvania, United States

Site Status

OB/GYN Associates of Erie

Erie, Pennsylvania, United States

Site Status

Research Protocol Management Specialists

Pittsburgh, Pennsylvania, United States

Site Status

Gilbert Teixeira, DO

East Providence, Rhode Island, United States

Site Status

Pharma Resource

East Providence, Rhode Island, United States

Site Status

Memorial Hospital of Rhode Island - Clinical Studies Center

Pawtucket, Rhode Island, United States

Site Status

Radiant Research, Inc.

Anderson, South Carolina, United States

Site Status

Columbia Women's Healthcare, LLC

Columbia, South Carolina, United States

Site Status

SC Clinical Research Center, LLC

Columbia, South Carolina, United States

Site Status

Radiant Research, Inc.

Greer, South Carolina, United States

Site Status

PMG Research of Charleston, LLC

Mt. Pleasant, South Carolina, United States

Site Status

Chattanooga Medical Research, LLC

Chattanooga, Tennessee, United States

Site Status

OB-GYN Centre of Excellence

Chattanooga, Tennessee, United States

Site Status

Advanced Therapeutics, Inc.

Johnson City, Tennessee, United States

Site Status

Johnson City Internal Medicine

Johnson City, Tennessee, United States

Site Status

Adult Care of Austin

Austin, Texas, United States

Site Status

Senior Adults Specialty Research

Austin, Texas, United States

Site Status

DiscoveResearch, Inc.

Beaumont, Texas, United States

Site Status

Beaumont Internal Medicine & Geriatric Associates

Beaumont, Texas, United States

Site Status

DiscoveResearch, Inc.

Bryan, Texas, United States

Site Status

DiscoveResearch, Incorporated

Bryan, Texas, United States

Site Status

Radiant Research, Inc.

Dallas, Texas, United States

Site Status

Advances In Health, Inc.

Houston, Texas, United States

Site Status

Centex Research, Inc. - Pineloch Medical Clinic

Houston, Texas, United States

Site Status

The Office of Dr. Steven Maislos, MD

Houston, Texas, United States

Site Status

Village Health Partners

Plano, Texas, United States

Site Status

Paragon Research Center, LLC

San Antonio, Texas, United States

Site Status

Radiant Research, Inc.

Murray, Utah, United States

Site Status

Advanced Clinical Research

West Jordan, Utah, United States

Site Status

Integra Trials, LLC

Arlington, Virginia, United States

Site Status

Washington Urology

Arlington, Virginia, United States

Site Status

Integrity Medical Research, LLC

Mountlake Terrace, Washington, United States

Site Status

Urology Northwest, PA

Mountlake Terrace, Washington, United States

Site Status

North Spokane Women's Clinic

Spokane, Washington, United States

Site Status

MBAL Trimontsium OOD

Plovdiv, , Bulgaria

Site Status

MBAL Ruse AD, Urologichno otdelenie,

Rousse, , Bulgaria

Site Status

UMBAL Aleksandrovska EAD

Sofia, , Bulgaria

Site Status

MBALSM N.I.Pirogov EAD

Sofia, , Bulgaria

Site Status

MBAL Doverie AD, Otdelenie po urologia

Sofia, , Bulgaria

Site Status

The Prostate Cancer Centre

Calgary, Alberta, Canada

Site Status

Lois Hole Hospital for Women, Royal Alexandra Hospital

Edmonton, Alberta, Canada

Site Status

Maritime Research Center

Bathurst, New Brunswick, Canada

Site Status

Maritime Research Center

Bathurst, New Brunswick, Canada

Site Status

The Male/Female Health and Research Centre, Royal Court Medical Centre

Barrie, Ontario, Canada

Site Status

Kingston General Hospital

Kingston, Ontario, Canada

Site Status

Centre for Applied Urological Research, Queen's University, Kingston General Hospital

Kingston, Ontario, Canada

Site Status

URLX Corporation

Ottawa, Ontario, Canada

Site Status

Sunnybrook Health Sciences Centre

Toronto, Ontario, Canada

Site Status

Diex Research Montreal Inc.

Montreal, Quebec, Canada

Site Status

Diex Research Sherbrooke Inc.

Sherbrooke, Quebec, Canada

Site Status

Prvni privatni chirurgicke centrum spol. s .r.o. - SANUS

Hradec Králové, , Czechia

Site Status

Nemocnice Jindrichuv Hradec

Jindřichův Hradec, , Czechia

Site Status

Oblastni nemocnice Kolin, a.s.

Kolin III, , Czechia

Site Status

Krajska zdravotni, a.s. - Masarykova nemocnice v Usti nad Labem, o.z.

Ústí nad Labem, , Czechia

Site Status

Ain Shams University Hospital

Cairo, , Egypt

Site Status

Suomen Terveystalo Turku

Turku, , Finland

Site Status

Klinische Forschung Berlin-Mitte GmbH

Berlin, , Germany

Site Status

Klinische Forschung Berlin

Berlin, , Germany

Site Status

Praxis fuer Urologie

Berlin, , Germany

Site Status

Duisburger Fachaerztegemeinschaft

Duisburg, , Germany

Site Status

ZKS Suedbrandenburg GmbH

Elsterwerda, , Germany

Site Status

Facharzt für Frauenheilkunde und Geburtshilfe

Frankfurt am Main, , Germany

Site Status

Urologische Praxis

Hagenow, , Germany

Site Status

Klinische Forschung Hamburg GmbH

Hamburg, , Germany

Site Status

Arztpraxis Dr. von Keitz

Marburg, , Germany

Site Status

Pharmakologisches Studienzentrum Chemnitz GmbH

Mittweida, , Germany

Site Status

Frauenarzt Praxis

München, , Germany

Site Status

Semmelweis Egyetem Altalanos Orvostudomanyi Kar Urologiai Klinika

Budapest, , Hungary

Site Status

Soproni Erzsebet Oktato Korhaz, Urologiai Osztaly

Sopron, , Hungary

Site Status

Donatella 99 Bt.

Szentes, , Hungary

Site Status

MAV Korhaz es Rendelointezet, Urologia

Szolnok, , Hungary

Site Status

Phylasis Clinicas Research S de RL de CV

Cuautitlán Izcalli, State of Mexico, Mexico

Site Status

Unidad de Diagnostico Integral

Colima, , Mexico

Site Status

NZOZ VIP - MED, Poradnia Urologiczna

Gdynia, , Poland

Site Status

SP ZOZ Wojewodzki Szpital Specjalistyczny im. J. Koraczaka

Słupsk, , Poland

Site Status

Specjalistyczny Gabinet Lekarski

Warsaw, , Poland

Site Status

Kemerovо Regional Perinatal Center

Kemerovo, , Russia

Site Status

Moscow State Healthcare Institution City Clinical Hospital #12

Moscow, , Russia

Site Status

Saint-Petersburg State Budgetary Healthcare Institution City Hospital #26

Saint Petersburg, , Russia

Site Status

Saint-Petersburg State Medical University I.P.Pavlov

Saint Petersburg, , Russia

Site Status

Saint-Petersburg State Healthcare Institution City Hospital # 15

Saint Petersburg, , Russia

Site Status

St. Petersburg State Healthcare Institution

Saint Petersburg, , Russia

Site Status

Siberian State Medical University

Tomsk, , Russia

Site Status

Parklands Hospital

Durban, KwaZulu-Natal, South Africa

Site Status

Department of Urology, Pusan National University Hospital

Pusan, , South Korea

Site Status

Department of Urology, Konkuk University Medical Center

Seoul, , South Korea

Site Status

Department of Urology, Ajou University Hospital

Suwon, , South Korea

Site Status

Kvinnohalsan Soder

Bandhagen, , Sweden

Site Status

Specialistmottagningen i urologi

Gothenburg, , Sweden

Site Status

Partus Kvinnohalsa

Gothenburg, , Sweden

Site Status

Me3plus Clinical Trials

Gothenburg, , Sweden

Site Status

Tudorkliniken, Specialistmottagningen i Urologi

Halmstad, , Sweden

Site Status

Vrinnevisjukhuset

Norrköping, , Sweden

Site Status

Regional Clinical Hospital, Department of Urology of Dnipropetrovsk State Medical Academy

Dnipropetrovsk, , Ukraine

Site Status

Regional Clinical Center of Urology and Nephrology

Kharkiv, , Ukraine

Site Status

Institute of Urology of AMS of Ukraine

Kyiv, , Ukraine

Site Status

Lugansk City Multi-Discipline Hospital #2, department of Urology

Luhansk, , Ukraine

Site Status

5Th City Clinical Hospital, Urology Department

Lviv, , Ukraine

Site Status

LTD Out-patient clinic of General practice and Family medicine

Odesa, , Ukraine

Site Status

Poltava Regional Clinical Hospital, Department of Urology

Poltava, , Ukraine

Site Status

Municipal Institution of Ternopil Regional Council, Ternopil University Hospital

Ternopil, , Ukraine

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Bulgaria Canada Czechia Egypt Finland Germany Hungary Mexico Poland Russia South Africa South Korea Sweden Ukraine

References

Explore related publications, articles, or registry entries linked to this study.

Stoniute A, Madhuvrata P, Still M, Barron-Millar E, Nabi G, Omar MI. Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults. Cochrane Database Syst Rev. 2023 May 9;5(5):CD003781. doi: 10.1002/14651858.CD003781.pub3.

Reference Type DERIVED
PMID: 37160401 (View on PubMed)

Wagg AS, Herschorn S, Carlsson M, Fernet M, Oelke M. A plain language summary of the likelihood of symptom relief for patients taking fesoterodine for overactive bladder. J Comp Eff Res. 2022 Sep;11(13):919-925. doi: 10.2217/cer-2022-0041. Epub 2022 Jul 26.

Reference Type DERIVED
PMID: 35881009 (View on PubMed)

Kaplan SA, Cardozo L, Herschorn S, Grenabo L, Carlsson M, Arumi D, Crook TJ, Whelan L, Scholfield D, Ntanios F; Assessment of Fesoterodine after Tolterodine ER (AFTER) Study Group. Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER. Int J Clin Pract. 2014 Sep;68(9):1065-73. doi: 10.1111/ijcp.12464. Epub 2014 Jun 4.

Reference Type DERIVED
PMID: 24898471 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0221094

To obtain contact information for a study center near you, click here.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A0221094

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.